• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Opioid Withdrawal Treatment Companies

    ID: MRFR/HC/6651-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Opioid withdrawal treatment companies specialize in the development and provision of therapies, medications, and solutions aimed at managing and alleviating symptoms associated with opioid withdrawal. These companies contribute to addressing the challenges individuals face when discontinuing opioid use and play a crucial role in addiction treatment. 

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Opioid Withdrawal Treatment Market Research Report - Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Opioid Withdrawal Treatment Market

    Opioid withdrawal treatment Market

     


    Latest Opioid withdrawal treatment Companies Updates:


    MindMaze: This neuroscience company is developing a non-invasive brain stimulation device, the nEUROMOD, which is undergoing clinical trials for opioid withdrawal symptom management.


    BioVie: In August 2023, this company announced successful Phase 2b data for BVT877, a non-opioid oral medication aimed at managing opioid withdrawal symptoms.


    EluSys Therapeutics: This biotech company is also working on a non-opioid treatment for opioid withdrawal, ELU-010, which is currently in Phase 2 clinical trials.


    List of Opioid withdrawal treatment Key companies in the market:



    • Orexo AB

    • Biodelivery sciences International Inc.

    • Viatris Inc.

    • Titan pharmaceuticals Inc.

    • Mallinckrodt pharmaceuticals

    • Alkermes

    • Teva pharmaceuticals industries Ltd.